Graves' disease is an autoimmune disorder that causes the thyroid to overproduce hormone. Dr. Guttler has treated Graves' disease for over 50 years and appeared on the NBC Today Show discussing this condition.
Graves' disease is an autoimmune disorder in which the immune system produces antibodies (TSI — thyroid-stimulating immunoglobulins) that mimic TSH and continuously stimulate the thyroid to produce excess hormone. It is the most common cause of hyperthyroidism in the United States, affecting approximately 1 in 200 people, with women affected 7–8 times more often than men.
Graves' disease results from a malfunction of the immune system. Normally, antibodies protect against foreign invaders. In Graves' disease, the immune system mistakenly produces TSI antibodies that bind to and activate TSH receptors on the thyroid, causing uncontrolled hormone production. Genetic factors play a role — Graves' disease runs in families — but environmental triggers such as stress, infection, pregnancy, and smoking also contribute.
Because Graves' disease causes hyperthyroidism, symptoms include rapid heartbeat, weight loss, heat intolerance, sweating, tremor, anxiety, irritability, and fatigue. Graves' disease has two additional hallmark features not seen in other causes of hyperthyroidism: Graves' ophthalmopathy (thyroid eye disease) — inflammation and swelling of the tissues around the eyes — and pretibial myxedema — a skin condition causing thickening and redness over the shins. Not all patients develop these features.
Diagnosis is confirmed by a suppressed TSH with elevated Free T4 and/or Free T3, combined with positive TSI or TRAb antibodies. A radioactive iodine uptake scan typically shows diffusely increased uptake throughout the gland, distinguishing Graves' from thyroiditis. Thyroid ultrasound with Doppler often shows increased blood flow ('thyroid inferno'). Eye examination is important to assess for ophthalmopathy.
Three definitive treatments are available. Antithyroid medications (methimazole) block hormone synthesis and can induce remission in 30–50% of patients after 12–18 months of therapy. Radioactive iodine (RAI) is the most commonly used definitive treatment in the US — it destroys thyroid tissue, usually resulting in hypothyroidism requiring lifelong levothyroxine. Thyroid surgery (total thyroidectomy) provides immediate control and is preferred in patients with large goiters, severe eye disease, or those who cannot tolerate medications.
Thyroid eye disease affects up to 50% of Graves' patients to some degree. Mild cases cause eye irritation, tearing, and puffiness. Moderate to severe cases cause proptosis (bulging eyes), double vision (diplopia), corneal exposure, and in rare cases, optic nerve compression threatening vision. Treatment ranges from lubricating eye drops and selenium supplementation to IV glucocorticoids, orbital radiation, and surgical decompression. Teprotumumab (Tepezza) is a newer biologic therapy approved for active thyroid eye disease.
Lecture 3: Hyperthyroidism & Graves' Disease
An overactive thyroid can cause heart palpitations, weight loss, and anxiety. Dr. Guttler explains Graves' disease, toxic nodules, and treatment choices.
Hyperthyroidism: When Your Thyroid Works Too Hard
Heart palpitations, weight loss, anxiety — an overactive thyroid produces a distinct set of symptoms. Learn how to recognize and treat hyperthyroidism.
Thyroid Eye Disease (Graves' Ophthalmopathy)
Graves' disease can affect the eyes, causing bulging, double vision, and discomfort. Dr. Guttler explains the connection and treatment options.